Mode of Adjuvant Action of the Nasally Delivered Cytokine Interleukin 1 Alpha
<p>Although monophosphoryl lipid A was recently approved by the Food and Drug Administration, more vaccine adjuvants are needed to meet the demand for vaccines against new, emerging, and re-emerging diseases. Additionally, characterizing the mechanisms of action of potent vaccine adjuvants is...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
2011
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10161/3897 |